Evidence map›Paper›PMID 42487131›Full record

ReviewLaboratory animal research2026

Advances in animal models of pigmentary skin disorders.

Zhenghong Chen, Yuan Yang, Min Xu, Xinli Chen, Yongliang Xiao, Liyuan Chen, Weiyu Chang, Hui Wu

Abstract readReview
In one paragraph

Review in Laboratory animal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhenghong Chen *Clinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yuan Yang *Clinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Min XuClinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xinli ChenClinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Yongliang XiaoClinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Liyuan ChenClinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Weiyu ChangClinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Hui WuClinical Pharmacy Center, The First Affiliated Hospital of Kunming Medical University, Kunming, China. kyz_ggyx@163.com.ORCID http://orcid.org/0009-0003-5966-3570

Funding

State key laboratory of neurology and oncology drug development young program SKLSIM-F-2024107The First affiliated hospital of Kunming medical university Doctoral foundation NO. 2022BS004Young and middle-aged academic and technical leaders in the reserve talent program 202305AC160016Yunnan Provincial Department of Education Science Research Fund Project NO. 2025J0323Yunnan Provincial Health Commission High-Level Medical Talent Training Program NO. L-2025020
6 · The paper itself

Abstract

Pigmentary cutaneous disorders are characterized by abnormal decreases or increases in melanin production, leading to altered skin coloration. These conditions include vitiligo, melasma, and post-inflammatory hyperpigmentation. The etiology of these dermatological manifestations is multifactorial, encompassing environmental triggers, hormonal fluctuations, psychological stress, and physical trauma. Although generally non-life-threatening, these disorders significantly impact patients' quality of life due to visible disfigurement and consequent psychosocial distress. This paper reviews the methods used to establish animal models for different types of pigmentary skin diseases and the research progress in this area. By examining published experimental studies, we have sorted out the modeling methods for these animal models and discussed their potential applications in clinical treatment research. Studies have shown that establishing appropriate animal models is beneficial for understanding the pathogenesis of pigmentary skin diseases and for conducting drug screening and dosage form optimization. Although no major breakthroughs have been made so far, the existing research results have provided an important foundation for future studies and supported the potential of these models in clinical treatment research. Establishing appropriate animal models for pigmentary skin diseases is both feasible and meaningful. With the continuous improvement of modeling techniques and a deeper understanding of the model mechanisms, animal models for pigmentary skin diseases will provide a powerful tool for verifying new treatment methods, thereby promoting progress in clinical treatment.

Indexed as

Animal modelCutaneous disordersMelasmaModeling methodPost-inflammatory hyperpigmentationVitiligo

Identifiers

PMID42487131
PMCPMC13390129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.